Form D · Biotechnology
Algaeon, Inc.
Indianapolis, IN · CIK 0001560376
Offering snapshot reported Jun 8, 2016 · SEC filing
- Reported sold
- $262K Offering amount: $4.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $75K Reported outside-investor minimum
- First sale
- Jun 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2016 | Initial | $261,800 | No comparison | 1 | SEC filing |
| Sep 17, 2014 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Nov 22, 2013 | Initial | $12,034 | No comparison | 1 | SEC filing |
| Oct 1, 2013 | Initial | $50,000 | No comparison | 1 | SEC filing |
| May 30, 2013 | Initial | $770,864 | No comparison | 25 | SEC filing |
| Dec 18, 2012 | Initial | $524,999 | No comparison | 5 | SEC filing |
| Oct 19, 2012 | Initial | $306,062 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264532
Source: Form D, filed Jun 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael E. Bosway | Director |
| Paul W. De Lacey | Director, Executive |
| Viren K. Grover | Director |
| Matthew Hall | Director |
| Tony Hubbard | Executive |
| Anthony Hubbard | Executive |
| William R. Kassebaum | Director, Executive |
| John A. Kassebaum | Director, Executive |
| James R. Miller | Director, Executive |
| Mike Neibler | Executive |
| Jonathan D. Rosen | Director, Executive |
| David A. Spoelstra | Executive |
| Brian Stemme | Director |
| Kip R. Zurcher | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7601 E. 88th Place Bldg. 3, Suite A
Indianapolis, IN, 46256
Indianapolis, IN, 46256